Skip to main content
. 2019 Mar 1;3(1):1–13. doi: 10.1159/000493642

Table 1.

Study efficacy endpoints, comparator device used for associated endpoint data collection, and statistical agreement between investigational device and comparator on an overall and activity grouped basis

Efficacy endpoint Comparator device Overall observed range Overall comparison (sleep, resting, moving) Sleep comparison Resting comparison Moving comparison
HR Actiheart 38–136 bpm corr. = 0.957, MAE = 2.0±5.1 bpm corr. = 0.865, MAE = 1.9±5.3 bpm corr. = 0.947, MAE = 1.9±4.0 bpm corr. = 0.900, MAE = 2.3±5.9 bpm

HRV (RMSSD) Actiheart 2.32–747.24 ms corr. = 0.965, MAE = 5.056±24.907 ms corr. = 0.939, MAE = 10.09±38.20 ms corr. = 0.977, MAE = 3.41±18.13 ms corr. = 0.996, MAE = 1.67±6.23 ms

HRV ratio (LF/HF) Actiheart 0.2–30.5 corr. = 0.861, MAE = 1.09±1.82 corr. = 0.845, MAE = 0.67±1.44 corr. = 0.825, MAE = 1.34±2.06 corr. = 0.892, MAE = 1.27±1.84

RR Capno-stream35 3–4 breaths/min N/A corr. = 0.697, MAE = 1.3±2.1 breaths/min N/A N/A

Step count independent observer with manual counter 467–716 steps/6 min N/A N/A N/A walking only, corr. = 0.950, MAE = 14.7±11.9 steps, error = 2.5% (average ground truth = 598.7 steps)

The HRV ratio for sleep was calculated using all qualified data pairs. corr., correlation; HF, high frequency; HR, heart rate; HRV, heart rate variability; LF, low frequency; MAE, mean absolute error; RMSSD, root mean square of successive differences; RR, respiration rate.